By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Pew PatriotsPew PatriotsPew Patriots
Notification Show More
Font ResizerAa
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Reading: First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
Share
Font ResizerAa
Pew PatriotsPew Patriots
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Search
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Have an existing account? Sign In
Follow US
First GLP-1 pill for weight loss, diabetes shows success in late-phase trial
News

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Jimmie Dempsey
Last updated: April 17, 2025 8:19 pm
Jimmie Dempsey Published April 17, 2025
Share
SHARE

Injectables for type 2 diabetes and weight loss could soon be a thing of the past.

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill.

The ACHIEVE-1 trial evaluated the efficacy of Orforglipron compared to placebo in adults with type 2 diabetes and “inadequate glycemic control with diet and exercise alone.”

FAKE OZEMPIC DRUGS FOUND IN US DRUG SUPPLY, FDA WARNS

The results showed lowered A1C (blood sugar) in patients by an average of 1.3% to 1.6% across doses, according to a press release.

More than 65% of participants taking the highest dose of the drug scored an A1C less than or equal to 6.5%, which is below the defined threshold for diabetes, according to the American Diabetes Association.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Trial participants also saw reduced weight by an average of 16 pounds, or 7.9%, at the highest dose.

Participants had not reached a weight plateau when the study ended, which suggests there was still weight to be lost, according to the researchers.

Eli Lilly

The trial also found that the overall safety and tolerability of the drug was consistent with the classic injectable GLP-1s, like Ozempic, Wegovy, Mounjaro and Zepbound.

If Orforglipron achieves approval by the U.S. Food and Drug Administration, Eli Lilly projected its confidence in launching the drug “worldwide without supply constraints.”

For more Health articles, visit www.foxnews.com/health

“This would further Lilly’s mission to reduce chronic diseases like type 2 diabetes, which is expected to impact an estimated 760 million adults by 2050,” the pharmaceutical company wrote in its announcement.

GLP-1 syringe

David A. Ricks, Eli Lilly chair and CEO, commented in a statement, “We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later this year.”

“As a convenient once-daily pill, Orforglipron may provide a new option and, if approved, could be readily manufactured and launched at scale for use by people around the world.”

  

Eli Lilly intends to submit Orforglipron for weight management to global regulatory agencies by the end of 2025, as well as for type 2 diabetes treatment in 2026, according to the company.

Read the full article here

You Might Also Like

Save big during HexClad’s Memorial Day sale and try out these mouth-watering Bite of Fox recipes

China’s newest humanoid robot is ready to serve like never before

White House proposal axes UN, NATO funds and halves State Department budget

Man taking credit for mysterious, viral prank in Oregon speaks out

Florida man offers police booze during car chase: ‘Don’t know if he was expecting us to just say ‘cheers”

Share This Article
Facebook Twitter Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend
Elizabeth Hurley’s debut with Billy Ray Cyrus, Jennifer Lopez’s daring dress mark week of red carpet moments
News

Elizabeth Hurley’s debut with Billy Ray Cyrus, Jennifer Lopez’s daring dress mark week of red carpet moments

Jimmie Dempsey Jimmie Dempsey May 31, 2025
Dodgers star Mookie Betts sustains freak toe injury while walking to bathroom
Poll: Overwhelming Majority of Americans Demand Big Pharma ACCOUNTABILITY for Vaccine Injuries
Scottie Scheffler breaks out in laughter after Peyton Manning’s errant tee shot reportedly hits house
All Of This Uncertainty Is Causing A Tremendous Amount Of Chaos For Businesses Of All Sizes
Michelle Obama facing backlash over claim about women’s reproductive health
Tinder’s new head pushes company to move away from ‘hookup’ reputation and rebrand for Gen Z users
News

Tinder’s new head pushes company to move away from ‘hookup’ reputation and rebrand for Gen Z users

Jimmie Dempsey Jimmie Dempsey May 31, 2025
Messerschmitt Me 262: Last Hope of the Luftwaffe?
Guns and Gear

Messerschmitt Me 262: Last Hope of the Luftwaffe?

Jimmie Dempsey Jimmie Dempsey May 31, 2025
Pat McAfee tells John Mellencamp to ‘shut the f— up’ after taking offense to Pacers hype-up speech
News

Pat McAfee tells John Mellencamp to ‘shut the f— up’ after taking offense to Pacers hype-up speech

Jimmie Dempsey Jimmie Dempsey May 31, 2025
Pew Patriots
  • News
  • Tactical
  • Prepping & Survival
  • Videos
  • Guns and Gear
2024 © Pew Patriots. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?